verified
SJR 0,55 · Q2
•
database
Scopus / SJR & Web of Science indexed
United States · Mary Ann Liebert Inc.
workspace_premium
Q2 — Medicine (miscellaneous)
lock
Subscription
Cancer Biotherapy and Radiopharmaceuticals
Cancer Biotherapy and Radiopharmaceuticals is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 72. It has an SJR impact factor of 0,55 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,55.
ISSN: 1084-9785
Publisher: Mary Ann Liebert Inc.
Category: Medicine (miscellaneous)
Indexation:
verifiedScopus / SJR
verifiedWeb of Science
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
0,55
Q2
H-index
72
Acceptance rate
pie_chart
28%
Selective
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
NPD
Subscription
Non-OA path
NPD
Metrics
Scimago and CountryOfPapers database fields
Scopus / SJR
Web of Science
SJR Impact
0,55
H-index
72
Docs (year)
92
Docs 3y
273
Total refs
3665
Cites 3y
666
Citable 3y
269
Cites/Doc 2y
2.23
Ref/Doc
39.84
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.